Pick the path that fits you. If none fits, write to us and we'll figure it out.
Medical professional or researcher
- Second read of the molecular profile (FGFR1 ×13, CCND1 ×20, ~80% neuroendocrine differentiation).
- Access to N-of-1, FGFR, neuroendocrine or precision oncology trials.
- Contacts with oncologists specialized in BC-NED or 11q13 amplification.
- Treatment line proposals targeted at the active drivers.
You have an audience, community or media outlet
The case needs to reach the right people: oncology, research or patients. Share the site or any social post. If you cover health, biotech or science, write to us and we'll send a press kit with verifiable data.
Background in software, AI, data or bioinformatics
We are building an open pipeline around the case: literature ingestion, molecular profiling, trial matching and decision models. All code and non-sensitive data are public. Where to start:
You are a patient or supporting someone in a similar situation
You don't have to contribute anything: if it helps to know this case exists and is documented in the open, that already serves its purpose. And if you'd like to share yours or write to Miriam, you can do it by email or DM. Miriam or someone on the team tries to reply when they can.
What moves the needle most
Fund the research behind the case
Every euro funds research applied to a single case: deep sequencing, molecular rebiopsy, transcriptomics, international second opinions and the N-of-1 trial when biology justifies it. Open budgets. Downloadable expense report.